How extensive are the human pregnancy outcome data for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead?

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead has no or limited pregnancy data (fewer than 300 outcomes) and no adequate, well-controlled studies in pregnant women; emtricitabine alone has over 1,000 exposed outcomes indicating no malformative or foetal/neonatal toxicity.